Amylyx Pharmaceuticals, Inc. AMLX
29.49
(0.65)
(2.16%)
as of 25 Sep
- Market cap
- $3.8B
- P/E
- 0.0×
Follow AMLX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
13.34 | 13.98 | 17.52 | 11.86 | |
Current Ratio |
13.70 | 14.27 | 17.85 | 12.12 | |
Net Debt/EBITDA |
9.26 | 8.44 | 6.32 | 5.35 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.88 | 0.85 | 0.89 | 0.72 | |
Capex/Depreciation |
0.02 | 0.09 | 7.83 | 0.03 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.33) | (0.30) | (0.33) | (0.28) | |
Capex per Share |
0.00 | 0.00 | (0.04) | 0.00 | |
Free Cash Flow per Share |
(0.33) | (0.30) | (0.37) | (0.28) | |
Cash per Share |
3.69 | 3.35 | 2.53 | 2.26 | |
Shareholders Equity per Share |
3.56 | 3.23 | 2.47 | 2.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.56 | 3.23 | 2.47 | 2.15 | |
Free Cash Flow |
(30.39) | (27.99) | (40.88) | (31.45) | |
Working Capital |
327.59 | 300.98 | 269.06 | 235.19 | |
Capital Expenditures |
(0.02) | (0.09) | (4.00) | (0.03) | |
Net Current Asset Value |
322.64 | 296.29 | 264.58 | 230.94 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.93 | 0.27 | — | — | |
Average Payables |
3.41 | 3.23 | 4.17 | 4.41 | |
Average Assets |
306.73 | 263.14 | 256.64 | 229.58 | |
Average Common Equity |
264.10 | 235.01 | 237.29 | 203.52 |
Columns are period end dates